1.Effect of Modified Qilang Prescription on Drug-dependent Constipation of Qi-Yin Deficiency Type
Mengxing CAO ; Mengen ZHOU ; Yong LI
Chinese Journal of Experimental Traditional Medical Formulae 2022;28(24):145-152
ObjectiveTo observe the clinical effect of modified Qilang prescription on the treatment of drug-dependent constipation of Qi-Yin deficiency type. MethodIn a randomized double-blind clinical trial, 160 patients with drug-dependent constipation were randomly divided into two groups, namely, the treatment group (80 cases) and the control group (80 cases). The treatment group was treated with modified Qilang prescription and lactulose oral liquid simulator, while the control group was treated with lactulose oral liquid and the simulator of modified Qilang prescription. The course of treatment of both groups was 8 weeks. The scores of main syndromes of constipation, traditional Chinese medicine (TCM) syndromes, patient assessment of constipation symptom (PAC-SYM) scale, and patient assessment of constipation quality of life (PAC-QOL) scale before and after treatment were recorded. The patients were followed up at the 2nd and 4th week after drug withdrawal. ResultAfter treatment, the full analysis set (FAS) analysis showed that the total effective rate was 91.14% (72/79) in the treatment group and 73.33% (55/75) in the control group. The treatment group had a higher total effective rate than the control group (Z=-6.62, P<0.01). The per-protocol set (PPS) analysis showed that the total effective rate was 93.51% (72/77) in the treatment group and 76.39% (55/72) in the control group. The treatment group had a higher total effective rate than the control group (Z=-6.77, P<0.05). After treatment, the FAS and PPS analysis showed that the main syndrome scores of constipation were lower in both groups than those before treatment (P<0.05). Except the syndromes of falling, overexertion defecation, and distension, the scores of other syndromes in the treatment group were lower than those in the control group (P<0.05). The scores of TCM primary syndromes in the two groups were lower than those before treatment (P<0.05), and the scores of the treatment group were significantly lower than those of the control group (P<0.05). The scores of TCM secondary syndromes in the treatment group were significantly lower than those before treatment (P<0.05). The syndrome scores of abdominal distension, fatigue, and lack of sleep in the treatment group were significantly lower than those in the control group (P<0.05). The scores of PAC-SYM scale were improved in both groups after treatment (P<0.05), and the treatment group was superior to the control group in improving fecal syndromes and abdominal syndromes. The scores of PAC-QOL scale were improved in both groups after treatment, and the treatment group was superior to the control group in improving patients’ physiological function, social psychology, anxiety, and satisfaction. After drug withdrawal, the recurrence rate was lower in the treatment group at the 2nd(χ2 =5.65,P<0.05) and 4th week (χ2 =12.37,P<0.01). Conclusionmodified Qilang prescription is effective in the treatment of drug-dependent constipation, and its clinical effect is better than that of lactulose oral liquid. The curative effect of modified Qilang prescription is stable and lasting without obvious adverse reactions.
2.Risk factors of abnormal urinary albumin/creatinine ratio in people with obesity
Zhe CAO ; Tongyue YANG ; Shiyu LIU ; Mengxing PAN ; Xuyang GONG ; Qianshuai LI ; Jiao WANG ; Lin ZHAO ; Guijun QIN ; Yanyan ZHAO
Chinese Journal of Endocrinology and Metabolism 2024;40(3):186-191
Objective:To explore the clinical characteristics and risk factors of abnormal urinary albumin/creatinine ratio(UACR) in obese population.Methods:Baseline data from 2011 to 2012 in Henan Sub-center of"Risk Evaluation of cAncers in Chinese diabeTic Individuals: A lONgitudinal(REACTION) study"were utilized and those of body mass index≥28 kg/m 2 were screened. The patients were divided into UACR normal group and UACR abnormal group(101 pairs) upon being matched on a 1∶1 basis by age and gender. Multivariate logistic regression analysis, receiver operating characteristic(ROC) curve, and restricted cubic spline(RCS)analysis were performed to explore the risk factors for abnormal UACR. Results:Compared with the normal UACR group, the UACR abnormal group had a higher number of alcohol consumers, a higher prevalence of hypertension, elevated systolic blood pressure, and triglyceride(all P<0.05). Multivariate logistic regression analysis showed that alcohol consumption( P=0.008), systolic blood pressure( P<0.001), triglyceride( P=0.049), and homeostasis model assessment for insulin resistance(HOMA-IR, P=0.033) were independent risk factors for abnormal UACR in obese people. The ROC curve analysis indicated that systolic blood pressure had the strongest diagnostic performance as a single factor(ROC curve area=0.801), and there was no significant difference in diagnostic performance compared to multiple factors combination. RCS analysis results showed that the probability of abnormal UACR increased monotonically with the increase of systolic blood pressure when the systolic blood pressure was between 130 and 158 mmHg(1 mmHg=0.133 kPa). When systolic blood pressure was not in the interval, the probability of abnormal UACR did not change significantly. The results of regression analysis of triglyceride subgroup showed that when triglyceride level was greater than or equal to 5.6 mmol/L, the risk of abnormal UACR level was significantly increased( P=0.029). Conclusion:Systolic blood pressure, triglyceride, HOMA-IR, and alcohol drinking history are independent risk factors for abnormal UACR in obese people. When systolic blood pressure is≥130 mmHg or triglyceride is≥5.6 mmol/L, the risk of abnormal UACR is significantly increased.